Dr. Darrin Disley serves as Co-Chief Executive Officer at Horizon Genomics. He Co-Founded & served as Board Member at GeoSpock. He serves as Board Member at Celixir. He also served as President, Chief Executive Officer & Board Member at Horizon Discovery. Darrin is a successful serial entrepreneur who has been involved in the start-up and growth of a number of business ventures. Since joining in 2007, he has been instrumental in growing Horizon from a small start-up in Cambridge in the UK into a rapidly growing multinational leader in the life sciences. During this time, Darrin has built a world-class management team, set the commercial and business strategy, led the company through multiple financing rounds including the Company's highly successful IPO in 2014, and driven the acquisitions of CombinatoRx, Sage Labs, Haplogen Genomics and Avvinity Therapeutics. Darrin is the holder of multiple business awards including Scrip Executive of the Year in 2014, a global award recognising leadership in biotechnology and pharmaceutical companies, UK quoted company entrepreneur of the Year in 2015, and was recently conferred with a lifetime held Queens Award for Enterprise Promotion by Her Majesty Queen Elizabeth the II in recognition of his contribution to Life Science entrepreneurship. He is a strong supporter of numerous academic, entrepreneurship and mentoring programs across the UK. Darrin also sits on the Boards of several companies and organizations including Cell Therapy Ltd, Desktop Genetics Ltd and the UK Bioindustry Association, and is an Angel investor in over 30 UK companies in the technology and life science sectors. He holds a PhD in Biotechnology from the University of Cambridge. He also serves as an Advisor, Life Sciences at Bailey Fisher Executive Search.